124 related articles for article (PubMed ID: 15862297)
1. HDM2 negatively affects the Chk2-mediated phosphorylation of p53.
Bjørling-Poulsen M; Meek D; Issinger OG
FEBS Lett; 2005 May; 579(12):2604-8. PubMed ID: 15862297
[TBL] [Abstract][Full Text] [Related]
2. HDM2 phosphorylation by MAPKAP kinase 2.
Weber HO; Ludwig RL; Morrison D; Kotlyarov A; Gaestel M; Vousden KH
Oncogene; 2005 Mar; 24(12):1965-72. PubMed ID: 15688025
[TBL] [Abstract][Full Text] [Related]
3. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
[TBL] [Abstract][Full Text] [Related]
4. ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation.
de Toledo SM; Azzam EI; Dahlberg WK; Gooding TB; Little JB
Oncogene; 2000 Dec; 19(54):6185-93. PubMed ID: 11175332
[TBL] [Abstract][Full Text] [Related]
5. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects.
Ionov Y; Le X; Tunquist BJ; Sweetenham J; Sachs T; Ryder J; Johnson T; Lilly MB; Kraft AS
Anticancer Res; 2003; 23(1A):167-78. PubMed ID: 12680209
[TBL] [Abstract][Full Text] [Related]
6. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
Vega FM; Sevilla A; Lazo PA
Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
[TBL] [Abstract][Full Text] [Related]
7. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
Chehab NH; Malikzay A; Appel M; Halazonetis TD
Genes Dev; 2000 Feb; 14(3):278-88. PubMed ID: 10673500
[TBL] [Abstract][Full Text] [Related]
8. c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF.
Dias SS; Milne DM; Meek DW
Oncogene; 2006 Oct; 25(50):6666-71. PubMed ID: 16702947
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
Kulikov R; Boehme KA; Blattner C
Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
[TBL] [Abstract][Full Text] [Related]
11. Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence.
Kane SA; Fleener CA; Zhang YS; Davis LJ; Musselman AL; Huang PS
Anal Biochem; 2000 Feb; 278(1):29-38. PubMed ID: 10640350
[TBL] [Abstract][Full Text] [Related]
12. A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines.
Chène P; Fuchs J; Bohn J; García-Echeverría C; Furet P; Fabbro D
J Mol Biol; 2000 May; 299(1):245-53. PubMed ID: 10860736
[TBL] [Abstract][Full Text] [Related]
13. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
[TBL] [Abstract][Full Text] [Related]
14. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
Latonen L; Taya Y; Laiho M
Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713
[TBL] [Abstract][Full Text] [Related]
15. The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.
Louria-Hayon I; Grossman T; Sionov RV; Alsheich O; Pandolfi PP; Haupt Y
J Biol Chem; 2003 Aug; 278(35):33134-41. PubMed ID: 12810724
[TBL] [Abstract][Full Text] [Related]
16. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.
Dumaz N; Meek DW
EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022
[TBL] [Abstract][Full Text] [Related]
17. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover.
Dias SS; Hogan C; Ochocka AM; Meek DW
FEBS Lett; 2009 Nov; 583(22):3543-8. PubMed ID: 19833129
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.
Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH
Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
